AR
ARKG.SW ARK Genomic
- CHF
No recent price
- Total assets
- 117M
- Expense ratio
- 0.78%
- Dividend yield
- -
- 1-year return
- +88.60%
- Holdings
- 10
- Since
- 2024
Fund data as reported by the issuer, updated Oct 30, 2026. Total assets are in the fund's base currency.
What does ARKG.SW invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (93.0%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (88.5%)
- Top 3 holdings: 27.4% of the fund
Asset allocation
- US stocks 93.0%
- Non-US stocks 10.5%
Top holdings
- Twist Bioscience Corp 10.08%
- Tempus AI, Inc. Class A Common Stock 9.45%
- 10X Genomics Inc 7.90%
- Crispr Therapeutics AG 5.22%
- Absci Corp 5.18%
ARK Genomic performance
Sharpe ratio 0.00- This year
- +92.70%
- 1 year
- +88.60%
- 3 years
- -
- 5 years
- -
Volatility 46.8% over 1 year. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
ARKG.SW price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
ARK Genomic top holdings
60.4% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Twist Bioscience Corp TWST.US | Healthcare | United States | 10.08% |
| Tempus AI, Inc. Class A Common Stock TEM.US | Healthcare | United States | 9.45% |
| 10X Genomics Inc TXG.US | Healthcare | United States | 7.90% |
| Crispr Therapeutics AG CRSP.US | Healthcare | United States | 5.22% |
| Absci Corp ABSI.US | Healthcare | United States | 5.18% |
| Natera Inc NTRA.US | Healthcare | United States | 4.92% |
| Illumina Inc ILMN.US | Healthcare | United States | 4.90% |
| CareDx Inc CDNA.US | Healthcare | United States | 4.82% |
| Personalis Inc PSNL.US | Healthcare | United States | 4.16% |
| Eli Lilly and Company LLY.US | Healthcare | United States | 3.76% |
ARKG.SW sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
ARKG.SW regional exposure
- North America88.5%
- Europe Developed7.4%
- United Kingdom3.3%
Share of the stocks in the fund.
Company size
Average market cap 5.69B- Mega cap4.1%
- Medium cap19.7%
- Small cap28.2%
- Micro cap48.2%
ARK Genomic fund profile
- Fund name
- ARK Genomic
- Ticker
- ARKG.SW
- Exchange
- SIX Swiss Exchange
- Issuer
- ARK Investment Management LLC
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Inception date
- Apr 12, 2024
- Trading currency
- CHF
- Expense ratio
- 0.78%